You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Velcade-dexamethasone

Showing 26 - 50 of 2,435
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stem Cell Transplantation Trial in Houston (Fludarabine, Dexamethasone, Cyclophosphamide)

Not yet recruiting
  • Stem Cell Transplantation
  • Houston, Texas
    M D Anderson Cancer Center
May 4, 2022

Multiple Myeloma Trial in Little Rock (Carfilzomib, Thalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Sep 1, 2022

Multiple Myeloma Trial in Little Rock (M-VTD-PACE, TT3-LITE Regimen (L-TT3))

Active, not recruiting
  • Multiple Myeloma
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences, Myeloma Institute f
Oct 4, 2021

Multiple Myeloma Trial in United States (Elotuzumab, Pomalidomide, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Boston, Massachusetts
  • +5 more
Oct 28, 2021

Multiple Myeloma Trial in Worldwide (Daratumumab, Bortezomib, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Whittier, California
  • +113 more
Jan 17, 2023

Multiple Myeloma, Chronic Kidney Disease Trial in United Kingdom (Bortezomib, Thalidomide, Bendamustine)

Completed
Has Results
  • Multiple Myeloma
  • Chronic Kidney Disease
  • Basingstoke, United Kingdom
  • +8 more
Jan 26, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Los Angeles (Bortezomib, Dexamethasone, Pelareorep)

Not yet recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Los Angeles, California
  • +1 more
Aug 19, 2022

Multiple Myeloma in Relapse Trial in Boston, Durham (Panobinostat, Dexamethasone, Lenalidomide)

Completed
  • Multiple Myeloma in Relapse
  • Boston, Massachusetts
  • +3 more
Sep 3, 2021

Multiple Myeloma Trial in Worldwide (Melphalan flufenamide (Melflufen), Dexamethasone, Bortezomib)

Terminated
  • Multiple Myeloma
  • Melphalan flufenamide (Melflufen)
  • +3 more
  • Boston, Massachusetts
  • +15 more
Mar 4, 2022

Plasma Cell Myeloma Trial (Bortezomib, Daratumumab and Hyaluronidase-fihj, Dexamethasone)

Not yet recruiting
  • Plasma Cell Myeloma
  • (no location specified)
Dec 22, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Columbus (Bortezomib, Daratumumab and Hyaluronidase-fihj,

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Nov 30, 2021

Plasma Cell Myeloma, Renal Failure Trial in Atlanta (Bortezomib, Daratumumab, Dexamethasone)

Recruiting
  • Plasma Cell Myeloma
  • Renal Failure
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jun 13, 2022

Myeloma Trial in Little Rock (Melphalan, Velcade, Thalidomide)

Active, not recruiting
  • Myeloma
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Dec 1, 2021

Multiple Myeloma Trial in Germany (Isatuximab, Lenalidomide, Bortezomib)

Recruiting
  • Multiple Myeloma
  • Aachen, Germany
  • +29 more
Apr 4, 2023

AL Amyloidosis Trial (procedure, drug, other)

Not yet recruiting
  • AL Amyloidosis
  • Autologous Hematopoietic Stem Cell Transplantation
  • +15 more
  • (no location specified)
Aug 28, 2023

Hematologic Malignancy Trial in United States (BBI608, Dexamethasone, Bortezomib)

Completed
  • Hematologic Malignancy
  • Denver, Colorado
  • +7 more
Apr 4, 2022

Multiple Myeloma Trial in France (Bendamustine, Velcade and Dexamethasone)

Completed
  • Multiple Myeloma
  • Bendamustine, Velcade and Dexamethasone
  • Amiens, France
  • +36 more
Dec 3, 2020

Light Chain (AL) Amyloidosis, Stage 3B Trial in Worldwide (Daratumumab, Bortezomib Injection, Dexamethasone oral tablet)

Recruiting
  • Light Chain (AL) Amyloidosis, Stage 3B
  • Créteil, France
  • +4 more
Sep 29, 2021

Myeloma, Newly Diagnosed, High Risk Trial in GuangZhou (bortezomib, Lenalidomide, Dexamethasone)

Unknown status
  • Myeloma
  • +2 more
  • GuangZhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Dec 15, 2020

Multiple Myeloma Trial in Little Rock (Velcade, Melphalan, Thalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Sep 7, 2021

Multiple Myeloma, Extramedullary Plasmacytoma Trial in Greece, Italy, Turkey (Daratumumab, Bortezomib, Cyclophosphamide)

Recruiting
  • Multiple Myeloma
  • Extramedullary Plasmacytoma
  • Athens, Greece
  • +7 more
Feb 4, 2021

Multiple Myeloma Trial (Renalidomide, Velcade, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • Renalidomide, Velcade, Dexamethasone
  • (no location specified)
Feb 19, 2020

AL Amyloidosis Trial in United States (Bortezomib, Cyclophosphamide, Dexamethasone)

Recruiting
  • AL Amyloidosis
  • Orange, California
  • +5 more
May 3, 2022

Amyloidosis Trial in Boston (Bortezomib, Dexamethasone, Melphalan)

Completed
Has Results
  • Amyloidosis
  • Boston, Massachusetts
    Boston Medical Center
Sep 4, 2020

Plasma Cell Myeloma Trial in Worldwide (Isatuximab SAR650984, Bortezomib, Lenalidomide)

Active, not recruiting
  • Plasma Cell Myeloma
  • Isatuximab SAR650984
  • +3 more
  • Fort Myers, Florida
  • +103 more
Nov 3, 2022